Laurence Lalanne
Biographic Data
| ID | 4452993 |
|---|---|
| NAME | Laurence Lalanne |
| GIVEN NAMES | Laurence |
| FAMILY NAME | Lalanne |
| SIGNATURE | LALANNE L |
| AFFILIATIONS | Université de Strasbourg |
| ORCID | 0000-0002-7012-7037 |
| VERIFIED | Yes |
| TOTAL WORKS | 9 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 9 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Exploration des déterminants bio-psycho-sociaux des niveaux de sévérité du trouble de l’usage d’opioïdes
Au cours des dernières décennies, il a été montré que le trouble de l’usage d’opioïdes (TUO) résultait des effets combinés de nombreux facteurs, notamment psychosociaux et neurobiologiques. Cette pluralité s’incarne dans un cadre théorique global : le modèle biopsychosocial de l’addiction. Si l’impact de chaque facteur sur la sévérité du TUO a été bien identifié, leur action combinée n’est pas connue. Dans ce contexte, le projet multidisciplinair…
Prevalence of stimulant use and the role of opioid agonist treatment among people who inject drugs in France
INTRODUCTION: The co-use of stimulants and opioids, including opioid agonist treatment (OAT), is very prevalent worldwide. A large body of data exists on the association between stimulant use and its health complications, and on OAT effectiveness among people with opioid use disorder. However, few data exist on stimulant-opioid co-use among people receiving OAT. Using data from the COSINUS cohort study, we investigated the association between the…
Medications for Opioid Use Disorder in People Who Inject Substances
BACKGROUND: Opioid Use Disorder (OUD) often provokes dramatic consequences in terms of increased morbi-mortality. Two medications have mainly been worldwide used for OUD (MOUD), buprenorphine and methadone. Recently, however, some reports have highlighted the use of Morphine Sulfate (MS) mainly obtained without a prescription but used as MOUD by opioid users and especially People Who Inject Substances (PWIS). We propose to characterize the preval…
Cost-effectiveness of drug consumption rooms in France
Our findings show that DCRs are highly effective and efficient to prevent harms in PWID in France, and advocate extending this intervention to other cities by adding drug consumption spaces inside existing harm reduction centers
Drug consumption rooms are effective to reduce at‐risk practices associated with HIV/HCV infections among people who inject drugs
AIMS: The primary aim of this study was to evaluate the impact of drug consumption rooms (DCRs) in France on injection equipment-sharing, while the secondary aims focused upon their impact on access to hepatitis C virus (HCV) testing and opioid agonist treatment (OAT). DESIGN: The COhort to identify Structural and INdividual factors associated with drug USe (COSINUS cohort) was a 12-month longitudinal study of 665 people who inject drugs (PWID), …
Impact of drug consumption rooms on non-fatal overdoses, abscesses and emergency department visits in people who inject drugs in France
BACKGROUND: The effectiveness of drug consumption rooms (DCRs) for people who inject drugs (PWID) has been demonstrated for HIV and hepatitis C virus risk practices, and access to care for substance use disorders. However, data on other health-related complications are scarce. Using data from the French COSINUS cohort, we investigated the impact of DCR exposure on non-fatal overdoses, abscesses and emergency department (ED) visits, all in the pre…
Link Between Perception of Treatment Need and Craving Reports in Addiction
Low perception of treatment need among subjects with severe addictions is associated to less retrospective report of craving, which may contribute to reduced efficiency of treatment. Further studies are needed to explore the mechanisms of the association
Autism Spectrum Disorder and Video Games
Do DSM-5 substance use disorder criteria differ by user care settings? An item response theory analysis approach
No prominent works on this page.
Do DSM-5 substance use disorder criteria differ by user care settings? An item response theory analysis approach
Autism Spectrum Disorder and Video Games
Impact of drug consumption rooms on non-fatal overdoses, abscesses and emergency department visits in people who inject drugs in France
BACKGROUND: The effectiveness of drug consumption rooms (DCRs) for people who inject drugs (PWID) has been demonstrated for HIV and hepatitis C virus risk practices, and access to care for substance use disorders. However, data on other health-related complications are scarce. Using data from the French COSINUS cohort, we investigated the impact of DCR exposure on non-fatal overdoses, abscesses and emergency department (ED) visits, all in the pre…
Link Between Perception of Treatment Need and Craving Reports in Addiction
Low perception of treatment need among subjects with severe addictions is associated to less retrospective report of craving, which may contribute to reduced efficiency of treatment. Further studies are needed to explore the mechanisms of the association
Drug consumption rooms are effective to reduce at‐risk practices associated with HIV/HCV infections among people who inject drugs
AIMS: The primary aim of this study was to evaluate the impact of drug consumption rooms (DCRs) in France on injection equipment-sharing, while the secondary aims focused upon their impact on access to hepatitis C virus (HCV) testing and opioid agonist treatment (OAT). DESIGN: The COhort to identify Structural and INdividual factors associated with drug USe (COSINUS cohort) was a 12-month longitudinal study of 665 people who inject drugs (PWID), …
Prevalence of stimulant use and the role of opioid agonist treatment among people who inject drugs in France
INTRODUCTION: The co-use of stimulants and opioids, including opioid agonist treatment (OAT), is very prevalent worldwide. A large body of data exists on the association between stimulant use and its health complications, and on OAT effectiveness among people with opioid use disorder. However, few data exist on stimulant-opioid co-use among people receiving OAT. Using data from the COSINUS cohort study, we investigated the association between the…
Medications for Opioid Use Disorder in People Who Inject Substances
BACKGROUND: Opioid Use Disorder (OUD) often provokes dramatic consequences in terms of increased morbi-mortality. Two medications have mainly been worldwide used for OUD (MOUD), buprenorphine and methadone. Recently, however, some reports have highlighted the use of Morphine Sulfate (MS) mainly obtained without a prescription but used as MOUD by opioid users and especially People Who Inject Substances (PWIS). We propose to characterize the preval…
Cost-effectiveness of drug consumption rooms in France
Our findings show that DCRs are highly effective and efficient to prevent harms in PWID in France, and advocate extending this intervention to other cities by adding drug consumption spaces inside existing harm reduction centers
Exploration des déterminants bio-psycho-sociaux des niveaux de sévérité du trouble de l’usage d’opioïdes
Au cours des dernières décennies, il a été montré que le trouble de l’usage d’opioïdes (TUO) résultait des effets combinés de nombreux facteurs, notamment psychosociaux et neurobiologiques. Cette pluralité s’incarne dans un cadre théorique global : le modèle biopsychosocial de l’addiction. Si l’impact de chaque facteur sur la sévérité du TUO a été bien identifié, leur action combinée n’est pas connue. Dans ce contexte, le projet multidisciplinair…
Medicine (8 works) · Opioid Use Disorder Treatment (8 works) · Psychiatry (8 works) · HIV, Drug Use, Sexual Risk (6 works) · Addiction (4 works) · Cohort (4 works) · Internal Medicine (4 works) · Psychology (4 works) · Substance Abuse Treatment and Outcomes (4 works) · Clinical Psychology (3 works)